Positron Emission Tomography: Physics and Radionuclide Production
Positron Emission Tomography: Physics and Radionuclide Production
Module Objectives
Upon completion of this module, students will be able to:
Review Nuclear Physics as it applies to PET imaging.
Describe positron decay and the production of annihilation photons.
List positron-emitting radionuclides and their properties.
Explain the function of radionuclide generators.
Describe the function and components of a cyclotron.
1. Positron Decay
Positron decay occurs in a neutron-deficient nucleus, where:
A proton transforms into a neutron.
Excess energy is released alongside a positively charged electron (known as a positron) and a neutrino.
Definition:
Positron: Has the same mass and characteristics as an electron but carries a positive charge.
Important notes:
The mass number remains unchanged, but the atomic number decreases by 1.
Positron decay conserves mass number and charge.
2. Secondary Annihilation Reaction
Characteristics of the reaction:
The positron, due to its positive charge, is attracted to an electron.
Upon colliding, they annihilate each other, converting mass entirely into energy.
This reaction produces two photons each at 511 keV, referred to as annihilation photons.
3. Beta Plus Decay
Also known as beta-positive decay:
Involves a proton decaying into a neutron, emitting a positron and a neutrino.
Reaction representation:
Key components:
Daughter nuclide has an atomic number decreased by 1.
Q-value signifies the energy released during the decay.
4. Nuclear Equations Summary
Types of decay and their representations:
Alpha decay:
Beta decay:
Positron emission:
Changes in mass/atomic numbers from various decay types:
Alpha decay decreases mass number (A) by 4, atomic number (Z) by 2.
Beta decay leaves A unchanged, and Z increases by 1.
Positron emission leaves A unchanged, reduces Z by 1.
5. Coincidence Detection
After annihilation, the rest masses of the particles transform into a pair of 511 keV photons:
Emitted approximately 180 degrees apart from each other.
Annihilation coincidence detection (ACD) refers to the near-simultaneous detection of these two photons to localize the origin point.
Theoretically, timing differences in photon detection can determine event locations:
Enables tomographic reconstruction without complex math algorithms.
Achieves timing accuracy on the order of picoseconds.
This may lead to an enhanced signal-to-noise ratio.
6. Factors Affecting Spatial Resolution
Critical factors affecting detector performance include:
Size of detector elements: Impacts internal resolution.
Positron range: The finite range of the positron affects the definitive location of each event.
Effective positron range refers to the average distance from the emitting nucleus to the end of the positron's trajectory.
Noncolinearity: Annoying phenomenon where annihilation photons are rarely emitted exactly 180 degrees apart, resulting in spatial resolution barriers.
7. Production of Radionuclides for PET
7.1 Regulatory Oversight
Regulation of PET radiopharmaceuticals involves:
Nuclear Regulatory Commission (NRC): Would oversee cyclotron-produced radioactive materials.
Food and Drug Administration (FDA): Controls the overall manufacturing processes of radiopharmaceuticals.
Approval requirements by FDA:
All PET radiopharmaceuticals must be manufactured following current Good Manufacturing Practices (cGMP).
7.2 Production Methods
PET radiopharmaceuticals can be produced via:
Generators: Typically located on-site.
Cyclotrons: Usually found in large-scale nuclear pharmacy facilities.
7.3 PET Generators
Example Generators:
Rb-82 generators: Potassium analog, used in myocardial perfusion imaging.
Ga-68 generators.
Rb-82 Generators:
Daughter product of Sr-82, which has a half-life of 25 days.
Rb-82 has a significantly shorter half-life of 75 seconds, requiring bedside elutions.
The generator is eluted with saline and injected directly into the patient.
Replacement frequency: Monthly.
Details about the injection process:
Upon elution, the generator must assess and monitor doses delivered to ensure patient safety.
7.4 Quality Control
Key protocols include:
Radionuclidic purity: Assess for Sr-82 and Sr-85 breakthroughs through daily tests.
Saline volume tracking: Maintain logs of saline eluted to check for any issues from excessive saline use.
Establish alert levels under which further action is needed (alert levels based on cumulative eluate volume or measurable radiation levels of Sr isotopes).
7.5 Ge-68/Ga-68 Generators
Parent radionuclide: Ge-68, which decays to Ga-68 (a positron emitter).
Key details:
Ge-68 half-life is 271 days; Ga-68 has a half-life of 68 minutes.
Ga-68 can be labeled with large complex molecules and is eluted hourly.
Regulatory criteria for impurities must be strictly monitored.
7.6 Cyclotron Operations
Cyclotron Functions:
Used to bombard targets with protons or deuterons to generate proton-rich radionuclides that emit positrons.
Operation Principles:
Consists of semicircular metal electrodes (dees) activated by alternating electrical fields inside a vacuum tank, aligned with a magnetic field to enhance particle acceleration.
Advantages:
Negative ion cyclotrons present various operational advantages, such as reduced nuclear activation and the ability to irradiate multiple targets.
7.7 Radionuclide Production by Cyclotrons
List of radionuclides produced with half-lives:
C-11: 20.3 minutes
N-13: 9.97 minutes
O-15: 2.03 minutes
F-18: 109.7 minutes
Ga-68: 68 minutes
Cu-64: 762 minutes
7.8 Synthesis Modules in Radiopharmaceutical Production
Large-scale production of PET radiopharmaceuticals involves automated synthesis modules:
Enabling efficient and controlled chemical reactions.
F-18 Labeling via Nucleophilic Substitution:
This reaction is critical to attach radioactive F-18 to compounds at specific locations, yielding the desired radiopharmaceutical.
Quality control protocols for F-18 FDG must include thorough checks at various stages to comply with FDA and USP regulations regarding purity and radioactive levels.
8. Quality Control for F-18 Radiopharmaceuticals
Essential tests involve assessing physical appearance, radionuclidic identity, radiochemical identity, and chemical purity:
Appearance: Must be colorless and free of particles.
Radionuclidic Identity: Half-life expectation must be between 105 and 115 minutes.
Chemical Purity: Testing for maximum permissible amounts of residual solvents and chemical impurities.
Conclusion
Understanding the physics of PET, including radionuclides and operational mechanics of generators and cyclotrons, is vital in the field of medical imaging and therapeutic practices. The advancements in quality control ensure safe and effective applications in clinical settings.